BioAge Labs (BIOA) Asset Utilization Ratio (2025 - 2026)
BioAge Labs' (BIOA) quarterly Asset Utilization Ratio came in at 0.03 in Q1 2026, up 620.74% year-on-year from 0.0 in Q1 2025, and down 0.64% quarter-over-quarter from 0.03 in Q4 2025.
BioAge Labs (BIOA) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
BioAge Labs has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.03 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.03, up 620.74% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.03 (up 620.74% YoY), and the FY2025 annual result was 0.03, changed N/A from the prior year.
- Asset Utilization Ratio came in at 0.03 for Q1 2026 at BioAge Labs, down from 0.03 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.03 in Q4 2025 to a low of 0.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.36 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.07 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.68 |
| 10 | BioAge Labs | 671.19 Mn | 288.00 Mn | -10.37 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.00 |